Alerts will be sent to your verified email
Verify Email
GLENMARK
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Glenmark Pharmaceuticals focuses on developing innovative drugs in inflammation, metabolic disorders, and pain, with a formulations business spanning multiple regions and therapeutic areas.
Glenmark Pharma major competitors are Aurobindo Pharma, Glaxosmithkline Phar, Alkem Laboratories, Abbott India, Ipca Laboratories, Ajanta Pharma, Gland Pharma.
Market Cap of Glenmark Pharma is ₹54,414 Crs.
While the median market cap of its peers are ₹47,511 Crs.
Glenmark Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Glenmark Pharma is 7.75 and is ranked 6 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | Mar Jun Sep Dec | ||
| Investor Presentation | May Jul Aug | Feb Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | Jun Sep Dec | Sep Dec | Mar | Sep | Sep | |||||||
| Conference Call | Mar | Mar Jun Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun | Mar Jun Sep Dec | Mar Jun Dec | Dec | Dec | |||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
